T-O: 0.795 (08:59:00)
Last updated: 17:00
EPS | 0.67 sen |
Trailing PE (Sector Median: 45.0) | 117.3 |
PEG | 117.3 |
Altman Z | 0.5 |
Beaver | 0.104 |
Current Ratio | 2.54 |
Debt-Equity (DE) Ratio | 0.27 |
FCF Yield | -2.77 % |
Revenue QoQ | -4.13 % |
Revenue YoY | -3.45 % |
Profit QoQ | -20.84 % |
Profit YoY | -44.99 % |
Profit Margin (Sector Median: 3.5) | 7.81 % |
ROE (ROIC: 1.3) | 1.49 % |
Dividend Per Share (DPS) | 0.17 sen |
Dividend Yield (DY) | 0.22 % |
Discounted Cash Flow (DCF) 5% Growth | 0.065 |
Discounted Cash Flow (DCF) 10% Growth | 0.085 |
Relative Valuation | 0.305 |
Graham Formula | 0.05 |
Graham Number | 0.26 |
Net Tangible Asset (NTA) | 0.0 | Consistent QR FV | N/APremium Access Only |
Forward PE FV Calculator | |
Latest Profit | 5.4 |
Expected Profit (Next QR) [M] | |
Expected Profit (After QR above) [M] | |
Expected Profit (After QR above) [M] | |
Estimated Fair Value |
Growth/Risk Fair Value Calculator | |
Expected growth (%) | |
Estimated downside / risk (%) | |
Estimated New DCF Fair Value |
Contract/Award Contribution Calculator | |
Contract/Award Value (in Million) | |
Estimated Contribution to Stock Price | |
Estimated New DCF Fair Value |
Profit-Based Calculator | |
Expected Profit (M) | |
for Year | |
Estimated New DCF Fair Value |
Revenue-Based Calculator | |
Expected Revenue (M) | |
for Year | |
Estimated New DCF Fair Value |
Market Pricing | |
Expected Profit (M) | 431.23 |
Expected Revenue (M) | 5521.45 |
Expected Growth (%) | 55.0 |
No transaction in the last 2 months.
Market Cap: 1371 M.
Number of Shares: 1736 M.
Adjusted Float: 17.37%.
Stock highly correlated with
ASIAFLE (92%)
EDARAN (91%)
ELSOFT (91%)
AMWAY (90%)
Manipulation Indicator: Very hard to manipulate.
TMC Life Sciences Berhad, through its subsidiaries, provides a range of fertility treatment services in Malaysia. It is engaged in the development, marketing, management of healthcare programs; provision of storage of cord blood and adult stem cells, stem cell therapy, and application services. It operates women's clinic and medical center; and provides gynecological and fertility problem management, as well as consultancy, and research and development services. The company operates TMC fertility centers. The company was founded in 1994 and is headquartered in Petaling Jaya, Malaysia.
Sectors: Trading & Services, Healthcare, Medical Service & Equipment, Health Care Providers, Budget 2021, Newly Classified Shariah-Compliant Securities
Code: 0101
Website: http://www.tmclife.com/
Related Links: Bursa | Annual Report | Announcement
Updated on 22-Nov-2019
Shareholder | Value (M) |
---|---|
Sasteria (M) Pte. Ltd. | 965.09 |
Dyam Tunku Ismail Ibni Sultan Ibrahim | 105.07 |
Credit Suisse | 67.6 |
Siow Wong Yen @ Siow Kwang Hwa | 31.9 |
UOB Kay Hian Pte. Ltd. | 29.0 |
CIMB Securities (Singapore) Pte. Ltd. | 10.75 |
Anastasia Amanda Beh Gaik Sim | 7.71 |
Lim Tien Lock Christopher | 5.59 |
Lim Zhong Yong | 4.12 |
UOB Kay Hian Pte Ltd | 3.8 |
Lim Gaik Bway @ Lim Chiew Ah | 3.64 |
Surinder Singh A/L Ranbir Singh | 3.58 |
Ho Lin Meng | 3.32 |
Wong Fuei Boon | 3.21 |
Yip Tuck Leong | 2.74 |
Joo & Lam Sendirian Berhad | 2.33 |
Ng Aik Sern | 2.28 |
Beh Eng Par | 2.07 |
Wong Choon Keit | 2.04 |
Lai Wei Chai | 1.97 |
Chiew Poh Cheng | 1.82 |
Lim Han Weng | 1.58 |
Hooi Thien Eng | 1.2 |
Mohd Salleh bin Hj Harun | 1.12 |
DFA Emerging Markets Small Cap Series | 1.08 |
Phillip Securities Pte. Ltd. | 1.03 |